Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cytoplasmic enzymes encompass a vast array of proteins that catalyze essential biochemical reactions within the cytosol of bacteria, fungi, and protozoa. These enzymes are fundamental to microbial life, facilitating processes such as DNA replication (e.g., DNA gyrase), RNA transcription (e.g., RNA polymerase), and the synthesis of vital metabolites like folic acid (e.g., dihydropteroate synthase) [StatPearls: NBK547703, NBK539761]. Because many of these enzymes possess structural and functional characteristics distinct from their human counterparts, they serve as critical targets for antimicrobial therapy, allowing for selective toxicity against pathogens [PubMed: 24853510]. For example, fluoroquinolones inhibit DNA gyrase and topoisomerase IV to disrupt DNA supercoiling, while sulfonamides and trimethoprim target the folate biosynthetic pathway to arrest growth [StatPearls: NBK547703, NBK539761]. In the context of infectious diseases, these enzymes are the primary sites of action for many frontline antibiotics used to treat respiratory, urinary, and systemic infections. However, the clinical efficacy of drugs targeting these enzymes is frequently compromised by the rapid development of antimicrobial resistance, often through chromosomal mutations that alter the enzyme's drug-binding site or through the acquisition of bypass mechanisms [PubMed: 30213556]. Furthermore, while these enzymes are targeted for their specificity, some drugs may exhibit off-target effects on human mitochondrial enzymes due to the evolutionary conservation between bacteria and mitochondria [PubMed: 23824696]. Monitoring efficacy typically involves measuring the Minimum Inhibitory Concentration (MIC) or systemic inflammatory markers like procalcitonin [PubMed: 21148468].
Inhibition of essential microbial metabolic and replicative enzymes, such as DNA gyrase, RNA polymerase, and enzymes in the folic acid synthesis pathway.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cytoplasmic enzyme.